Back to Authors

Poterucha, John J.

Mayo Clinic

Mayo Clinic

Citations 14

Longterm clinical and radiological follow‐up of living liver donors
Murad, Sarwa Darwish , Fidler, Jeff L. , Poterucha, John J., Sánchez, William , Jowsey‐Gregoire, Sheila G. , Nagorney, David M. , Rosen, Charles B. , Darwish Murad, Sarwa, Jowsey, Sheila G, Nagorney, David, Fidler, Jeff L. , Heimbach, Julie K. , Sanchez, William , Darwish Murad, Sarwa

Liver Transplantation | May 4, 2016 | Volume: 22 | Issue: 7 | Pages: 934-942

10.1002/lt.24442 Get It

Although short‐term risks of living donor hepatectomy have been well defined, little is known about the longterm impact. We aimed to perform a systematic follow‐up to screen for unanticipated health consequences of liver donation. All donors who were more than 1 year from donation were invited for a systematic evaluation including physical and laboratory assessment, quality of life questionnaire, and magnetic resonance imaging (MRI)/magnetic resonance cholangiopancreatography (MRCP). Those unable to return were offered the questionnaire and laboratory assessment at home. Out of our total of 97 donors, 45 returned for a full assessment and 23 completed labs and survey locally (total n = 68; 70%) after a median of 5.5 years (1.5‐10.9 years) after donation. The only laboratory abnormality was a significant decrease in platelet count (median 198 ×109/L versus 224 ×109/L before donation; P < 0.001), whereas 93% of patients were still above normal limits. No late biliary strictures or other structural abnormalities were found on MRI/MRCP. Liver regeneration was complete. Spleen volume did significantly increase (median 278 cm3 versus 230 cm3 before donation; P < 0.001) without resulting in lowered platelets (P = 0.73). The most common complaints were persistent incisional numbness and changed bowel habits. Seven donors (11%) reported problems obtaining insurance. The vast majority (97%) would have donated again. In conclusion, longterm outcome following liver donation appears satisfactory. None of our donors have developed occult biliary strictures, failure of regeneration, abnormal liver function, or other important health consequences after a median of 5.5 years from surgery. These findings can be used when counseling potential donors in the future. Liver Transplantation 22 934–942 2016 AASLD
Spur cell anemia in the setting of progressive liver allograft failure
Partain, Daniel K. , Poterucha, John J., Ashrani, Aneel A. , Thompson, Carrie A. , Botero, Juliana Perez , Shi, Min , Partain, Daniel K

American Journal of Hematology | February 14, 2016 | Volume: 91 | Issue: 10 | Pages: 1061-1061

10.1002/ajh.24331 Get It

Potential Efficacy of Pegylated Interferon-α and a Nucleos(t)ide Analogue as Combination Therapy for HBeAg-Positive Chronic Hepatitis B
Kim, W. Ray , Gross, John B. , Stadheim, Linda, Poterucha, John J., Stadheim, Linda M, Wi, Chung‐Il

Gut and Liver | July 20, 2015 | Volume: 10 | Issue: 4 | Pages: 611-616

10.5009/gnl14256 Get It

Liver Transplantation and Hepatitis B
Poterucha, John J., Wiesner, Russell H., Wiesner, Russell H.

Annals of Internal Medicine | April 12, 2013 | Volume: 126 | Issue: 10 | Pages: 805-807

10.7326/0003-4819-126-10-199705150-00012 Get It